Several studies suggest that fibronectin servesas a mitogen and survival factor for NSCLC [93], and fibronectin was recentlyshown to stimulate tumor cell expression of matrix metalloproteinases,proteases implicated in metastatic disease [94]. Here, FN1 is linked to metastatic neoplasm.